Evidence map›Paper›PMID 42731006›Full record

ReviewMagyar onkologia2026

[Sentinel node biopsy and lymphatic mapping from a nuclear medicine perspective: principles, methods and experiences in Szeged].

Zsuzsanna Besenyi, Máté Lázár, László Pávics, Gábor Sipka, István Farkas

Abstract readReviewEnglish Abstract
In one paragraph

Review in Magyar onkologia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Zsuzsanna BesenyiNukleáris Medicina Intézet és Teranosztikus Központ, Szegedi Tudományegyetem, Szeged, Hungary. besenyi.zsuzsanna@szte.hu.
Máté LázárPozitron Medical Diagnosztika Központ, Budapest, Hungary.
László PávicsNukleáris Medicina Intézet és Teranosztikus Központ, Szegedi Tudományegyetem, Szeged, Hungary. besenyi.zsuzsanna@szte.hu.
Gábor SipkaNukleáris Medicina Intézet és Teranosztikus Központ, Szegedi Tudományegyetem, Szeged, Hungary. besenyi.zsuzsanna@szte.hu.
István FarkasNukleáris Medicina Intézet és Teranosztikus Központ, Szegedi Tudományegyetem, Szeged, Hungary. besenyi.zsuzsanna@szte.hu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo summarise the principles, indications, radiopharmaceuticals, preoperative imaging and intraoperative detection methods of sentinel node biopsy (SNB) and lymphatic mapping, and to present the experience of the Department of Nuclear Medicine and Theranostics, University of Szeged.

methodsThis review is based on current EANM/SNMMI guidelines, the relevant international literature and institutional data.

resultsSNB has become an accepted component of oncological care in melanoma, breast cancer, gynaecological, urological and head-and-neck malignancies. Lymphoscintigraphy combined with SPECT/CT is mandatory in numerous indications. At the University of Szeged, preoperative isotope-guided sentinel node localisation combined with intraoperative gamma probe-assisted sentinel node biopsy has been performed in nearly 6,000 patients since 1999.

conclusionsSNB is a multidisciplinary procedure requiring nuclear medicine, surgery and pathology. Hybrid tracers and multimodal intraoperative detection further improve detection rates and reduce false-negative results.

Indexed as

Lymph NodesNeoplasmsNuclear MedicineSentinel Lymph NodeSentinel Lymph Node BiopsyBreast NeoplasmsFemaleHumansLymphatic MetastasisLymphoscintigraphyMelanomaRadiopharmaceuticalsSingle Photon Emission Computed Tomography Computed TomographyTomography, Emission-Computed, Single-PhotonRadiopharmaceuticals

Identifiers

PMID42731006
PMCPMC13577716

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.